Intrinsic Value of S&P & Nasdaq Contact Us

Becton, Dickinson and Company BDX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
$318.86
+104.8%
Analyst Price Target
$193.80
+24.4%
SharesGrow 7-Criteria Score All 7 criteria scored · income-related highlighted on this page

Becton, Dickinson and Company (BDX) has shown moderate revenue growth over the past 3 years, expanding from $18.9B to $21.8B (average +5%/yr). Net income reached $1.7B, reflecting earnings decline at -1.1%/yr on average. The net profit margin is 7.7%, which is moderate. The company has maintained profitability in all 4 of the past 4 years, demonstrating a consistent earnings track record. The gross margin is 45.4% (moderate), with a +0.5pp trend over the period. With a $56B market cap and MOAT composite score of 73/100, the company has a strong competitive position.

Criteria proven by this page:

  • GROWTH (40/100, Partial) — growth is present but not consistently above 5% across both metrics
  • PAST (100/100, Pass) — proving consistent earnings. Looking at the full 41-year history, the company was profitable in 41 of 41 years — a perfect long-term track record
  • INCOME (45/100, Partial) — the company is profitable but margin is below 15%
  • MOAT (73/100, Pass) — strong gross margins and market scale prove a durable competitive advantage

Overall SharesGrow Score: 56/100 with 2/7 criteria passed.

56/100
SG Score
View full scorecard →
VALUE
36/100
Price-to-Earnings & upside
→ IV page
~
FUTURE
46/100
Analyst consensus
→ Forecast
PAST
100/100
4/4 yrs profit
EPS $5.83
Proven by this page
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
73/100
Score: 73/100
GM 45.4% (+0.5pp)
Proven by this page
~
GROWTH
40/100
Rev +5%/yr
NI -1.1%/yr
Proven by this page
~
INCOME
45/100
Margin 7.7%
$21.8B
Proven by this page
Becton, Dickinson and Company Earnings and Revenue History
Analyst Forecast →
Revenue  Actual & Estimate
Earnings & Profit Margin  Actual & Estimate
Metric TTM FY2025 FY2024 FY2023 FY2022
Revenue $21.92B$21.84B$20.18B$19.37B$18.87B
Gross Profit $10.03B$9.92B$9.13B$8.17B$8.48B
Gross Margin 45.8%45.4%45.2%42.2%44.9%
Operating Income $2.72B$2.58B$2.4B$2.11B$2.28B
Net Income $1.76B$1.68B$1.71B$1.48B$1.78B
Net Margin 8%7.7%8.4%7.7%9.4%
EPS (Diluted) $6.13$5.83$5.86$4.94$5.88
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message